Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment?

AIDS. 2001 Jan 26;15(2):153-9. doi: 10.1097/00002030-200101260-00003.
No abstract available

Publication types

  • Editorial
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active / statistics & numerical data*
  • HIV Infections / drug therapy*
  • Health Policy
  • Humans
  • Physician's Role*
  • Treatment Refusal*

Substances

  • Anti-HIV Agents